HeadOn Headache Relief Children's
Natural health product licensed in Canada
- Licence holder
- Arvidis, Inc.
- NPN or DIN-HM
- 80007327
- Status
- Active licence
- Licence date
- 29 August 2008
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Homéopathique
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Kali bichromicum Source : Kali Brichromicum Potency : 0.01 % of 6X dilution | 6 X |
Non-medicinal ingredients
propylèneglycol, diazolidinyl urée, Stéarate de Sodium, Butylcarbamate d'iodopropynyle, EDTA de tétrasodium, triéthanolamine, Alcool éthylique, Eau, Steareth 21
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 6 years ; maximum: 11 years | Not specified | Not specified |
Uses authorised in Canada
Homeopathic medicine for headache pain relief. Homeopathic medicine for headache relief.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Keep out of reach of children under 6 years of age. Consult a doctor if your child has an allergic reaction, pain lasting more than 3 days or if there is no relief within the first 24 hours of treatment. Avoid contact with eyes, wounds, mucous membranes, broken or irritated skin. Do not apply a heating pad to forehead.
- Contre-indications
Do not use if your child is allergic or hypersensitive to any ingredient in this product.
- Effets indésirables connus
Irritation or allergic reaction may occur in some children. Test by applying product to a small area of forehead and wait 30 minutes. If skin appears normal, proceed with directions.
Source
Official Health Canada record, licence 80007327
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.